WS #11266

From 498 msgs · 8 key-dev

The data dump reveals a complex market picture. The dominant narrative is a broad tech selloff, with the Nasdaq-100 sliding over 2%, but several high-significance counter-signals and MAG7-specific developments are emerging. Tesla delivered a blowout quarter, crushing Wall Street estimates with record Q2 deliveries of 480,126 vehicles, beating the 402,776 consensus. This is a direct contradiction to the prevailing tech weakness and should act as a strong positive catalyst for TSLA. Meanwhile, Microsoft is surging (+4.9%) on news of a $2.5 billion investment in a new enterprise AI company, 'Microsoft Frontier Company', and a report that it is merging its Copilot chatbots. This positive MSFT signal also runs counter to the macro tech selloff. Apple is reportedly raising foldable iPhone (iPhone Ultra) orders to 10 million units, a bullish supply-chain signal for AAPL. On the geopolitical front, Iran issued a new warning threatening 'forceful response' to vessels not following Tehran-approved routes in the Strait of Hormuz, escalating tensions. This is countered by a Bloomberg report that some EU nations now see Hormuz transit fees as unavoidable, suggesting a potential normalization. Oil prices remain stable near pre-war levels, but the threat is re-escalating. The chip selloff continues with no new catalysts, and the dollar's strength is flagged as a risk for a yen carry trade blowup. The narrative arc is: Tech selloff STABLE (but with MAG7 carve-outs bullish for TSLA, MSFT, AAPL), Oil/Geopolitical risk ESCALATING (Iran threat), Rate-cut/gold narrative STABLE.

Topics

Key developments

  • Tesla delivers record Q2 deliveries, crushing estimates
  • Microsoft launches $2.5B enterprise AI company, merges Copilot chatbots
  • Iran threatens 'forceful response' for vessels not using Tehran-approved Hormuz routes
  • Apple raises foldable iPhone orders to 10 million units
  • US jobs data weaker than expected, fueling rate-cut hopes
  • Meta rolls out new gaming app 'Pocket'
  • Revolution Medicines reports positive Phase 3 pancreatic cancer data, raises $2.4B
  • Dollar strength risks another yen carry trade blowup